Indeed, components of the TGFβ pathway such as SMAD4 and the ligand receptor TGFBR2 are encoded by classic tumour suppressor genes, which undergo direct loss-of-function mutation during tumorigenesis in certain cancers27. This evidence concerns the gene TGFBR2 and neoplasm.